Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,400,052 papers from all fields of science
Search
Sign In
Create Free Account
CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine
Known as:
CTX/DOX/PRED/VCR
, ACOP
, cyclophosphamide, doxorubicin, prednisone, and vincristine protocol
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Broader (5)
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine
Doxorubicin
Expand
Narrower (3)
CAUP protocol
CHOP-14 protocol
CHOP-21 protocol
CDE protocol-cyclophosphamide/doxorubicin/etoposide
CHOP regimen
Doxorubicin Hydrochloride
Prednisone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)
U. Vitolo
,
M. Trněný
,
+18 authors
L. Sehn
2016
Corpus ID: 208436118
Background: Rituximab (R) plus CHOP (R-CHOP) is standard-of-care treatment for previously untreated diffuse large B-cell lymphoma…
Expand
2009
2009
Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B‐cell lymphoma
V. Ribrag
,
C. Gisselbrecht
,
+7 authors
N. Mounier
Cancer
2009
Corpus ID: 20860586
Bortezomib demonstrated promising activity in lymphomas. The authors conducted a randomized phase 2 trial of frontline rituximab…
Expand
2009
2009
Japanese phase II study of 90Y‐ibritumomab tiuxetan in patients with relapsed or refractory indolent B‐cell lymphoma
K. Tobinai
,
Takashi Watanabe
,
+17 authors
K. Endo
Cancer Science
2009
Corpus ID: 31067630
There is no data about the efficacy and safety of radioimmunotherapy with 90Y‐ibritumomab tiuxetan in patients with relapsed or…
Expand
2008
2008
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma
S. Kılıçkap
,
B. Yavuz
,
+7 authors
I. Barista
Medical Oncology
2008
Corpus ID: 44478149
AbstractBackground The addition of rituximab to doxorubicin-containing standard chemotherapy significantly improves response to…
Expand
Highly Cited
2007
Highly Cited
2007
Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
K. Herrmann
,
H. Wieder
,
+10 authors
T. Dechow
Clinical Cancer Research
2007
Corpus ID: 42897751
Purpose: To evaluate 3′-deoxy-3′-[18F]fluorothymidine-positron emission tomography (FLT-PET) for early monitoring response of…
Expand
2007
2007
Domain Organization and Movements in Heavy Metal Ion Pumps
Yuta Hatori
,
E. Majima
,
T. Tsuda
,
C. Toyoshima
Journal of Biological Chemistry
2007
Corpus ID: 31663853
To study domain organization and movements in the reaction cycle of heavy metal ion pumps, CopA, a bacterial Cu+-ATPase from…
Expand
Highly Cited
2003
Highly Cited
2003
Understanding copper trafficking in bacteria: interaction between the copper transport protein CopZ and the N-terminal domain of the copper ATPase CopA from Bacillus subtilis.
L. Banci
,
I. Bertini
,
S. Ciofi‐Baffoni
,
R. Del Conte
,
L. Gonnelli
Biochemistry
2003
Corpus ID: 38590154
In this paper the interaction of cytoplasmic CopZ and the N-terminal domain of the CopA ATPase from Bacillus subtilis has been…
Expand
2001
2001
Changing Incidence and Survival in Patients with AIDS-Related Non-Hodgkin's Lymphomas in the Era of Highly Active Antiretroviral Therapy (HAART)
K. Chow
,
P. Mitrou
,
Kerstin Geduldig
,
E. Helm
,
D. Hoelzer
,
H. Brodt
Leukemia and Lymphoma
2001
Corpus ID: 36335401
To determine role of highly active antiretroviral therapy (HAART) and additional factors in incidence and outcome of patients…
Expand
2001
2001
Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis
M. Yamaguchi
,
Miho Kimura
,
+7 authors
H. Shiku
Bone Marrow Transplantation
2001
Corpus ID: 23394822
We describe a case of relapsed intravascular lymphomatosis (IVL) successfully treated with autologous PBSCT. A 59-year-old…
Expand
Highly Cited
1995
Highly Cited
1995
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
C. U. Groot
,
Anton Hagenbeek
,
L. Verdonck
,
B. Löwenberg
,
F. Rutten
Bone Marrow Transplantation
1995
Corpus ID: 24622903
A prospective randomized clinical trial with simultaneous data collection for an economic appraisal was carried out to assess the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE